TGF-Beta Blockade Increases Renal Inflammation Caused by the C-Terminal Module of the CCN2
The CCN family member 2 (CCN2, also known as connective tissue growth factor) may behave as a risk biomarker and a potential therapeutic target for renal disease. CCN2 participates in the regulation of inflammation and fibrosis. TGF-β is considered...
Saved in:
| Main Authors: | Raquel Rodrigues-Díez, Sandra Rayego-Mateos, Macarena Orejudo, Luiz Stark Aroeira, Rafael Selgas, Alberto Ortiz, Jesús Egido, Marta Ruiz-Ortega |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2015/506041 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TWEAK promotes peritoneal inflammation.
by: Ana Belen Sanz, et al.
Published: (2014-01-01) -
Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage
by: Sandra Rayego-Mateos, et al.
Published: (2018-01-01) -
Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology
by: Jose Luis Morgado-Pascual, et al.
Published: (2018-01-01) -
Targeting TGFβR2‐mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancer
by: Huocong Huang, et al.
Published: (2019-10-01) -
Cardioselective beta-adrenoreceptor blockade with betaxolol in cardiovascular therapy
by: D. V. Duplyakov
Published: (2009-08-01)